Table 1.
Baseline characteristics of CRIC study participants
| Variables | Overall (n=2604) | ASCVD Event within 10 Years | |
|---|---|---|---|
| No (n=2352) | Yes (n=252) | ||
| Age, mean (SD), yr | 55.8 (11.7) | 55.5 (11.8) | 59.0 (9.8) |
| Male, No. (%) | 1354 (52.0) | 1212 (51.5) | 142 (56.3) |
| Black race, No. (%) | 1013 (38.9) | 898 (38.2) | 115 (45.6) |
| Body mass index, mean (SD), kg/m2 | 31.7 (7.8) | 31.7 (7.9) | 32.0 (7.1) |
| Current smoking, No. (%) | 314 (12.1) | 262 (11.1) | 52 (20.6) |
| HbA1c, mean (SD), % | 6.4 (1.5) | 6.4 (1.5) | 7.0 (1.6) |
| Diabetes mellitus, No. (%) | 1082 (41.6) | 931 (39.6) | 151 (59.9) |
| Use of glucose-lowering medications, No. (%) | 620 (24.0) | 534 (22.9) | 86 (34.3) |
| Systolic BP, mean (SD), mm Hg | 127.0 (21.0) | 126.0 (20.7) | 136.1 (21.6) |
| Diastolic BP, mean (SD), mm Hg | 72.7 (12.4) | 72.5 (12.2) | 74.3 (13.7) |
| Use of BP-lowering medications, No. (%) | 2282 (87.6) | 2041 (86.8) | 241 (95.6) |
| Total cholesterol, mean (SD), mg/dl | 188.4 (44.5) | 188.2 (43.7) | 190.2 (51.3) |
| LDL cholesterol, mean (SD), mg/dl | 106.6 (35.3) | 106.5 (34.9) | 107.6 (38.8) |
| HDL cholesterol, mean (SD), mg/dl | 48.8 (16.1) | 49.1 (16.2) | 45.8 (15.0) |
| Apolipoprotein B, mean (SD), mg/dl | 85.6 (24.4) | 85.4 (24.1) | 87.7 (27.1) |
| Use of statin medications, No. (%) | 1184 (45.8) | 1045 (44.8) | 139 (55.4) |
| eGFR, mean (SD), ml/min per 1.73 m2 | 56.0 (24.7) | 56.9 (25.0) | 47.2 (20.4) |
| Urine ACR, median [IQR], mg/g | 39.1 [7.3, 391.2] | 34.7 [6.7, 344.7] | 224.0 [18.3, 1062.3] |
| Hemoglobin, mean (SD), g/dl | 12.7 (1.8) | 12.8 (1.8) | 12.3 (1.9) |
| hsCRP, median [IQR], mg/L | 2.4 [1.0, 6.1] | 2.3 [1.0, 6.0] | 3.0 [1.2, 7.9] |
| Troponin-T, median [IQR], pg/ml | 9.7 [4.5, 18.9] | 9.3 [4.1, 17.4] | 16.0 [8.9, 31.6] |
| NT-proBNP, median [IQR], pg/ml | 106.5 [49.3, 249.7] | 99.3 [46.5, 229.5] | 207.9 [95.7, 457.5] |
IQR, interquartile range.